Generics 7

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Flecainide manufacturers

7 products found

Filters

7 products found

flecainide

Tablets 100 mg

Dossier type
CTD
Dossier status
Outdated
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq
Manufacturer #419

The manufacturer based in Europe, has decades of experience in the industry. They focus on a diverse range of products, including prescription drugs, over-the-counter medications, and medical devices. Their portfolio covers a variety of therapeutic areas, with key focuses on cardiovascular health, oncology, and pain management. The manufacturer holds numerous patents for their innovative products and adheres to strict GMP standards for both the European Union and the United States. They distribute their products across key regions in Europe, North America, and other international markets. Their production lines include solid oral dosage forms, injectables, and liquids, offering a wide range of treatment options for patients.

Manufacturer usually replies in 5 days

flecainide

Capsules, prolonged release (PR) 50 mg, 100 mg, 150 mg, 200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #2110
A pharmaceutical manufacturer based in the EU that has been active for 50+ years. The company's production lines are GMP-compliant. Key production lines are Rx and OTC. Main therapeutic areas include the cardiovascular system, CNS, and diabetes. Main dosage forms include solid, liquid, semi-solid and injectable forms.

Manufacturer usually replies in 6 days

flecainide

Capsules, prolonged release (PR) 50mg. 100mg. 150mg. 200mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Manufacturer #304
This international development company specializes in innovative medical treatments and boasts a highly agile structure, allowing for rapid response to urgent medical needs. Focusing on novel therapies, they leverage a dynamic team with an entrepreneurial spirit. They are part of a larger €300 million organization spanning three continents, specializing in pharmaceuticals, solutions, and development. While their primary focus is not disclosed, they emphasize innovation in a "brave new world" suggesting a commitment to emerging medical technologies and treatments.

Manufacturer usually replies in 10 days

Want to see all 7 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Markets of interest Flecainide is prescribed for preventing certain types of life threatening irregular heartbeats. As an antiarrhythmic drug, flecainide works by slowing electrical signals in the heart to stabilize the heart rhythm. The medication is prescribed to treat ventricular and subventricular tachycardias, abnormal heart rate over 100 beats per minute. Due to proarrhythmic properties of this medication and and lack of evidence of improved survival for any antiarrhythmics, the drug use should be restricted to patients with life-threatening ventricular arrhythmias. The drug is available for sale in different forms such as tablets (at concentrations of 50mg, 100mg, 150mg) and prolonged release (at concentrations of 50mg. 100mg. 150mg. 200mg) from manufacturers in various countries including Y. The leading flecainide manufacturers and distributors are based in India, Argentina and the United Kingdom. Licensing and brand names Flecainide was approved by the FDA for medical use in the United States in 1985 and available for sale as a generic medication. Flecainide is marketed under the brand name Tambocor and also sold in certain countries under such trade names as Flecaine, Apocard, Almarytm, and Ecrinal. The leading flecainide supplier and manufacturer is the Indian company Aurobindo. Other manufacturing companies from Macedonia, United States and European Union have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with flecainide as an active ingredient. Target supply price The wholesale acquisition cost for flecainide oral tablets 50 mg is around 31 USD for a supply of 50, in the United States, and around 33 USD for the same amount of tablets at 100mg concentration. The retail price of this medication in the EU depending on this substance concentration in tablets ranges from 15 to 36 EUR for the same amount of tablets. The medication wholesale prices and commercial terms can vary depending on the supplier. Information from manufacturers We provide a detailed list of the flecainide manufacturers and suppliers that you are looking for. You can also find the dossier status of the drug that you order, and the GMP approvals of the different variants of the medication. The product description of all flecainide suppliers contains essential information about the medication, including clinical data, stability zones, and a list of countries where flecainide is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms.Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified flecainide suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible